Clinical audit on management of β-thalassemia major in Minia General Hospital

Background Beta-thalassemia is one of the common genetic disorders in our community. Therefore, it is deemed necessary to study and probe it to encompass all aspects of this disorder. Aim The aim of this study was to determine the adherence of management of β-thalassemia major in Minia General Hospi...

Full description

Bibliographic Details
Main Authors: Mostafa F Ibrahim, Hosney M Ahmed, Khaled H Hassan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Al-Azhar Assiut Medical Journal
Subjects:
Online Access:http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2020;volume=18;issue=2;spage=146;epage=151;aulast=
_version_ 1818955864198873088
author Mostafa F Ibrahim
Hosney M Ahmed
Khaled H Hassan
author_facet Mostafa F Ibrahim
Hosney M Ahmed
Khaled H Hassan
author_sort Mostafa F Ibrahim
collection DOAJ
description Background Beta-thalassemia is one of the common genetic disorders in our community. Therefore, it is deemed necessary to study and probe it to encompass all aspects of this disorder. Aim The aim of this study was to determine the adherence of management of β-thalassemia major in Minia General Hospital to an established Standard for the Clinical Care of Children with Thalassemia in the UK. Patients and methods This study included 100 children with β-thalassemia major who were receiving regular blood transfusion; data of the patients were collected and analyzed for audit against established Standards for the Clinical Care of Children with Thalassemia in the UK; values were expressed in terms of percentage. Results The diagnosis of β-thalassemia major in our study was made mainly on the basis of the clinical background confirmed by complete blood count, hemoglobin electrophoresis, and serum ferritin level; the frequency of investigations in our study showed that abdominal ultrasound was performed regularly in most of our patients (93%), followed by liver function (74%), serum ferritin (65%), hepatitis marker (57%), echocardiography (47%), and assessments of weight and height − sitting and standing (43%), follicle-stimulating hormone, luteinizing hormone (7%), thyroid-stimulating hormone, triiodothyronine, thyroxine (7%), fundus examination (7%), audiometry (3%), oral glucose tolerance test (3%), vitamin D level (3%), and DEXA scan (1%); the assessment of puberty was not performed. The most common complication in our study was splenomegaly (80%), followed by bone deformities (76%), slowed growth rates (69%), and infection (47%), followed by bone osteoporosis (27%), heart problems (24%), chronic hepatitis, or liver fibrosis (19%). Iron-chelation therapy was used by 53% of our patients. Deferasirox is the main line (38%); hydroxyurea was used by 41% of our patients. Conclusion As a conclusion, we found that lines of management of β-thalassemia major in Minia General Hospital were not enough and not performed systematically in comparison with Standards for the Clinical Care of Children with Thalassemia in the UK.
first_indexed 2024-12-20T10:44:50Z
format Article
id doaj.art-53a74e32f388427286e2f262f853e6d7
institution Directory Open Access Journal
issn 1687-1693
language English
last_indexed 2024-12-20T10:44:50Z
publishDate 2020-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Al-Azhar Assiut Medical Journal
spelling doaj.art-53a74e32f388427286e2f262f853e6d72022-12-21T19:43:26ZengWolters Kluwer Medknow PublicationsAl-Azhar Assiut Medical Journal1687-16932020-01-0118214615110.4103/AZMJ.AZMJ_85_19Clinical audit on management of β-thalassemia major in Minia General HospitalMostafa F IbrahimHosney M AhmedKhaled H HassanBackground Beta-thalassemia is one of the common genetic disorders in our community. Therefore, it is deemed necessary to study and probe it to encompass all aspects of this disorder. Aim The aim of this study was to determine the adherence of management of β-thalassemia major in Minia General Hospital to an established Standard for the Clinical Care of Children with Thalassemia in the UK. Patients and methods This study included 100 children with β-thalassemia major who were receiving regular blood transfusion; data of the patients were collected and analyzed for audit against established Standards for the Clinical Care of Children with Thalassemia in the UK; values were expressed in terms of percentage. Results The diagnosis of β-thalassemia major in our study was made mainly on the basis of the clinical background confirmed by complete blood count, hemoglobin electrophoresis, and serum ferritin level; the frequency of investigations in our study showed that abdominal ultrasound was performed regularly in most of our patients (93%), followed by liver function (74%), serum ferritin (65%), hepatitis marker (57%), echocardiography (47%), and assessments of weight and height − sitting and standing (43%), follicle-stimulating hormone, luteinizing hormone (7%), thyroid-stimulating hormone, triiodothyronine, thyroxine (7%), fundus examination (7%), audiometry (3%), oral glucose tolerance test (3%), vitamin D level (3%), and DEXA scan (1%); the assessment of puberty was not performed. The most common complication in our study was splenomegaly (80%), followed by bone deformities (76%), slowed growth rates (69%), and infection (47%), followed by bone osteoporosis (27%), heart problems (24%), chronic hepatitis, or liver fibrosis (19%). Iron-chelation therapy was used by 53% of our patients. Deferasirox is the main line (38%); hydroxyurea was used by 41% of our patients. Conclusion As a conclusion, we found that lines of management of β-thalassemia major in Minia General Hospital were not enough and not performed systematically in comparison with Standards for the Clinical Care of Children with Thalassemia in the UK.http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2020;volume=18;issue=2;spage=146;epage=151;aulast=chelation therapyiron overloadthalassemia majorukβ-blood transfusion
spellingShingle Mostafa F Ibrahim
Hosney M Ahmed
Khaled H Hassan
Clinical audit on management of β-thalassemia major in Minia General Hospital
Al-Azhar Assiut Medical Journal
chelation therapy
iron overload
thalassemia major
uk
β-blood transfusion
title Clinical audit on management of β-thalassemia major in Minia General Hospital
title_full Clinical audit on management of β-thalassemia major in Minia General Hospital
title_fullStr Clinical audit on management of β-thalassemia major in Minia General Hospital
title_full_unstemmed Clinical audit on management of β-thalassemia major in Minia General Hospital
title_short Clinical audit on management of β-thalassemia major in Minia General Hospital
title_sort clinical audit on management of β thalassemia major in minia general hospital
topic chelation therapy
iron overload
thalassemia major
uk
β-blood transfusion
url http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2020;volume=18;issue=2;spage=146;epage=151;aulast=
work_keys_str_mv AT mostafafibrahim clinicalauditonmanagementofbthalassemiamajorinminiageneralhospital
AT hosneymahmed clinicalauditonmanagementofbthalassemiamajorinminiageneralhospital
AT khaledhhassan clinicalauditonmanagementofbthalassemiamajorinminiageneralhospital